Notably, CNTNAP2 expression is decreased in the hippocampus of Alzheimer’s disease (AD) patients due to the downregulation by STOX1 (van Abel et al., 2012), supporting the association between CNTNAP2 level and memory. This evidence concerns the gene STOX1 and early-onset autosomal dominant Alzheimer disease.